LX3050 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

21 results for “LX3050”

Trials

Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis

15 participants · First posted Feb 19, 2009

Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate

208 participants · First posted May 18, 2009

A Study to Determine the Safety and Efficacy of LX3305 in Subjects With Active Rheumatoid Arthritis

10 participants · First posted Aug 16, 2011

Drugs

LXG250

LXH005

Investigational

LV305

News

Lexeo to Acquire Mantle Therapeutics for Up to $21.3M, Adding Four Frataxin-Targeting FA Programs

First Patient Dosed in Pioneering ZOLAR Trial of TLX300-CDx for Advanced Soft Tissue Sarcoma

Lexeo Therapeutics Reports Promising Phase I/II Data for Gene Therapy LX2020 in Rare Heart Disease

Page 1 of 3